Delivery Order SPE2DB22D1017-SPE2DB25FF4HD

Award Date 1/29/25
Potential Completion Date 2/20/25
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,151.52 firm fixed-price delivery order is for the supply of IMBRUVICA 420 MG TABLET 28S, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 firm fixed-price delivery order is for the supply of IMBRUVICA 420 MG TABLET 28S, a specialty pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award, SPE2DB20D1050|SPE2DB25FH44H, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 firm-fixed-price delivery order is for the supply of IMBRUVICA 280 MG TABLET 28S, a pharmaceutical product, to support military healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 420 mg tablets, a specialty medication, with a ceiling value of $7,575.75 and a completion date of January 24, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. In addition to this specific delivery order, AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $81,233.35 firm fixed-price delivery order is for the supply of IMBRUVICA 420 MG TABLET 28S, a specialty medication. The contract has a completion date of February 9, 2023 and is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 firm fixed-price delivery order contract is for the supply of IMBRUVICA 420 MG TABLET 28S, a specialty pharmaceutical product. The contract has an ultimate completion date of January 8, 2025 and was awarded on December 16, 2024. No set-aside designation was used. AmerisourceBergen holds a significant...
This federal contract award, valued at $15,691.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 140 MG CAPSULE 90S, a specialty medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a Ceiling Value of $15,151.52 and is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The contract provides for the delivery of IMBRUVICA 280 MG TABLET 28S, a prescription medication, to support military treatment facilities, veterans' healthcare programs, and...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,645.34 firm fixed price delivery order is for the supply of IMBRUVICA 280 MG TABLET 28S, a prescription medication, with a period of performance through August 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999, for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,116.87 fixed-price delivery order is for the supply of IMBRUVICA 140 mg capsules, a specialty medication used for various medical treatments. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF4HD
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 firm-fixed-price delivery order is for the supply of IMBRUVICA 420 MG TABLET 28S, a specialty medication.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC covers critical medical commodities across multiple therapeutic areas.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and no subcontractors are referenced. The award supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the DLA's procurement of essential pharmaceutical and medical supplies.

Generated 4/30/25, 10:24 AM